| Brickell Biotech is a clinical-stage pharmaceutical company focused on the development of prescription therapeutics for the treatment of debilitating skin diseases. Co.'s pipeline consists of therapeutics for hyperhidrosis and other prevalent dermatological conditions. Co.'s Sofpironium bromide is a topical anticholinergic product candidate, developed for once-daily treatment of primary axillary hyperhidrosis in adult and pediatric patients nine years of age and older. Sofpironium bromide was retrometabolically designed. Retrometabolic drugs are intended to exert their action topically and are metabolized once absorbed into the blood. We show 5 historical shares outstanding datapoints in our coverage of BBI's shares outstanding history.|
Understanding the changing numbers of BBI shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like BBI versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching BBI by allowing them to research BBI shares outstanding history
as well as any other stock in our coverage universe.